Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kangfang Biologics
Guangzhou, Guangdong, China
- Ownership
- Private
- Development stage
- Other
01
Overview
As of Sep 2025, Kangfang Biologics has seven self-developed products approved for marketing in China, including the global first-in-class PD-1/CTLA-4 bispecific antibody for cervical cancer, the PD-1/VEGF bispecific antibody for NSCLC showing superior efficacy over pembrolizumab, and ongoing pivotal trials across various indications. The company has over 50 innovative projects under development, including 15 first-in-class or best-in-class bispecific/multispecific antibodies and ADCs.
- Therapeutic areas
- OncologyImmunologyMetabolic Disorders
- Modalities
- Bispecific monoclonal antibodyMonoclonal antibodyAntibody-drug conjugatemRNA-based drugsCell therapy
- Industry
- Biotech
02
Partnerships
Summit Therapeutics (global license for Yivofisi/Ivoxidan/AK112; $5B deal)Lepu Biopharmaceuticals (Putouheng commercial rights)Sichuan Kelun Pharmaceutical (Ketailai commercial rights)
Beyond the preview
Go deeper on Kangfang Biologics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kangfang Biologics.